BioStock: PHI’s CEO reflects on global roadshow success

During the early summer, medical technology company PHI embarked on a global tour to showcase their latest HoloMonitor products, lab instruments designed for non-invasive cell culture analysis and future applications in cell quality control in regenerative medicine. BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2023/06/phis-ceo-reflects-on-global-roadshow-success/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/